Use this dropdown to select your preferred language.
Boehringer Ingelheim has been committed to providing innovative treatments in Human and Animal Health for over 130 years. Boehringer Ingelheim is a family-owned, R&D-driven company and one of the top 20 pharmaceutical companies in the world. Our employees create value through innovation in Human Health, Animal Health and contract manufacturing of biopharmaceuticals.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
At Boehringer Ingelheim, the development of medicines for people and animals is at the heart of our work. Our mission is to develop innovative therapies that change lives. Since its founding in 1885, Boehringer Ingelheim has been an independent family company. We are free to pursue our long-term vision, anticipating the health challenges of the future and targeting those areas of need where we can deliver the greatest benefits
Philip Morris Singapore Pte. Ltd. is a subsidiary company of Philip Morris International and it is the leading tobacco company in Singapore. The company’s direct sales and distribution operation was established in 1998, but PMI’s brands have been on the market in Singapore for many years.
Make History together.
At PMI we are embracing change together to deliver a smoke-free future. We value an inclusive and diverse work environment and see diversity as our greatest strength. Working with our employees, we are driving forward discussions on gender, LBGTQ+, ethnicity, disability, and mental health.
Come be part of a creative, collaborative culture in which leaders will nurture and help you develop your professional skills.
As a leading research-driven biopharmaceutical company Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. The Regional Center Vienna is responsible for the business in Austria and more than thirty countries in Central and Eastern Europe and Central Asia, as well as Switzerland and Israel and is also the group’s main cancer research site.